banner

Stock Chart Videos back to homepage

American Oriental Bioengineering Stock Chart Analysis American Oriental Bioengineering Stock Chart Analysis(0)

The AOB stock chart is hitting the watchlist to hold support at $1.  With the stock closing at $1.04 of Wednesday, a close stop-loss is available with resistance in front at $1.05 and $1.13, but not again until near $1.30 which provides a substantial upside for technical traders.  Volatile market conditions warrant a close watch on support should downward pressure come.



According to the Company’s website,

American Oriental Bioengineering Inc. (Abbreviation in Chinese: Meidong, Abbr in English: AOBO) was registered in Nevada, U.S.A. The history of AOBO can be traced back to the 70′s and the 90′s respectively of the 20th century. AOBO is a multinational holding company that is rooted in China with full spectrum of pharmaceutical manufacturers, pharmaceutical distributors, research and development, raw material plantations, holistic healthcare and nutraceutical products.

AOB stock chart technical analysis:

American Oriental Engineering (AOB) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Video Chart of the Day:  Shengkai Innovations, Inc. (VALV) Video Chart of the Day: Shengkai Innovations, Inc. (VALV)(0)


Bottom Play! We’re kicking off the new week with a look at VALV, a play that has lost more than 50 percent of its value in the last four weeks. Technical traders will have their eyes peeled for the $1.25 mark to hold as a bottom support as the chart tries to halt the fall and re-gain some ground. Video chart brought to you by PennyPayDay.com.


Shengkai Innovations is primarily engaged in the design, manufacture and sale of ceramic valves, high-tech ceramic materials and the provision of technical consultation and related services. The Company’s industrial valve products are used by companies in the electric power, petrochemical and chemical, metallurgy and other industries as high-performance, more durable alternatives to traditional metal valves. The Company was founded in 1994 and is headquartered in Tianjin, the PRC.

The Company is one of the few ceramic valve manufacturers in the world with research and development, engineering, and production capacity for structural ceramics and is able to produce large-sized ceramic valves with calibers of 6″ (150mm) or more. The Company’s product portfolio includes a broad range of valves that are sold throughout the PRC, to Europe, North America, United Arab Emirates, and other countries in the Asia-Pacific region. The Company has over 400 customers, and is the only ceramic valve supplier qualified to supply SINOPEC. The Company joined the supply network of China National Petroleum Corporation (“CNPC”) in 2006 and subsequently received a CNPC Certificate of Material Supplier for valve products in 2011.

Shengkai Innovations (VALV) Stock Quote and News:


Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of this website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The following news is published as information only for our readers. otcshowcase.com is a third party publisher of news and research .Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Reginicin (RGIN) Stock Chart Video Reginicin (RGIN) Stock Chart Video(0)


The Regenicin stock chart is a low-volume play that appears to be trying to trend off the bottom. There is a solid positive divergence with the MACD and a support level at 16 cents that technical traders will be watching with resistance at 22 cents.


Regenicin, Inc. (OTCBB:RGIN ) is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin, which was founded in 2010, has assembled a world-class management team with a proven track record for developing and bringing innovative medical devices and biotechnology products to market. The company is publicly traded with headquarters in New Jersey. More information on the Company can be found at www.regenicin.com.

Regenicin, Inc. (RGIN) Stock Quote and News:


Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of this website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The following news is published as information only for our readers. otcshowcase.com is a third party publisher of news and research .Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Star Bulk Carriers Corp. (SBLK) Video Stock Chart 2/14/2011 Star Bulk Carriers Corp. (SBLK) Video Stock Chart 2/14/2011(0)

The SBLK stock chart held a base last week with a low of $2.42.  Technical traders will be watching this chart as it is forming a PPO/ADX “pincher play” formation, which can be pretty reliable as a bottom play.  We are watching for the support level to hold and for the reversal to begin as the first resistance doesn’t come into play until the price per share reaches the area of $2.65.  Pretty nice risk versus reward setup with a close support level.  The base must hold because if it fails, there isn’t any strong support until $2.20.  View the video at www.stockmarketvideocharts.com.

The Star Bulk Carriers Corp. (NASDAQ:SBLK) is a feature chart of Quality Stocks.

Please visit www.QualityStocks.net today!

Exit Only, Inc. (EXTO.PK) Video Stock Chart 1/20/2011 Exit Only, Inc. (EXTO.PK) Video Stock Chart 1/20/2011(0)

Exit Only, Inc. (Pinksheets:EXTO) has a chart that appears to be trying to breakout of a flag pattern and is on radar with technical traders for a larger move.

We have partnered with several websites to bring annotated video charts to one location and created www.stockmarketvideocharts.com.  Please visit this site where you can begin seeing featured video charts and learn technical analysis at the same time.  Tell your friends as we continue to grow and bring in more videos.

The video chart for EXTO.PK is presently on the front page, but is also located at:   http://www.stockmarketvideocharts.com/?p=203

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.